This systematic review of preclinical animal models raises mechanistic questions about PDT's potential to trigger systemic immunity but does not provide clinical evidence sufficient to guide practice or confirm efficacy in humans.
This is a narrative review synthesizing existing literature on ncRNA regulation of SLC transporters in cancer, raising mechanistic questions rather than presenting new empirical evidence or a definitive answer.
This is a narrative review synthesizing preclinical and observational evidence on VAP-1 biology in cancer; it raises translational questions and proposes therapeutic targets but does not report primary trial data, effect sizes, or clinical outcome comparisons.